Lungpacer Medical announced today that physicians performed the first commercial procedures using its FDA-cleared AeroPace ...
Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation’s largest healthcare providers and top hospitals has ...
According to an economic analysis of the REVISE trial, IV pantoprazole, previously proven to reduce clinically significant ...
MedPage Today on MSN
Stress Ulcer Prophylaxis Cost-Effective in the ICU
In the economic analysis of the REVISE trial (E-REVISE), the incremental cost of randomization to IV pantoprazole (Protonix ...
Around the world, people are racing to design and manufacture much-needed ventilators to address a global lack of supply. One New York hospital has reportedly attempted treating two patients per ...
Among critically ill adults receiving invasive mechanical ventilation, early use of an automated closed-loop ventilation system did ...
Bracing for a surge of Covid-19 patients and facing shortages of the resources necessary to keep the sickest patients alive, hospitals and governments are grappling with the reality of having to ...
In severe acute respiratory failure, patients with new onset interstitial lung disease had similar ICU mortality and ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Mortality could be as high as two thirds among patients with COVID-19 who require ventilation, new ...
Dec 2 (Reuters) - With the COVID-19 pandemic sweeping across its shores earlier this year, the U.S. government in April announced orders for almost $3 billion of ventilators for a national stockpile, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback